Dermal Cooling System for Cryotherapy of Common Skin Conditions
Primary Purpose
Skin Lesion
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Dermal Cooling System
Sponsored by
About this trial
This is an interventional treatment trial for Skin Lesion
Eligibility Criteria
Inclusion Criteria:
- Male or female subjects > 18 years of age.
- Subject has benign superficial lesion(s) associated with common skin conditions amenable to cryosurgical treatment including, for example, psoriasis, acne, rosacea, and sebaceous hyperplasia.
- Subject is willing to have up to 40 test sites treated.
- Subject has read and signed a written informed consent form.
Exclusion Criteria:
- Physician prescribed procedures in the area of intended treatment in the previous 6 months (e.g., photodynamic therapy, intense pulsed light therapy, laser surgery).
- Dermatological conditions (e.g. vitiligo, open wounds, infection, pre-cancerous or malignant lesions) in the location of the treatment sites that would, in the professional opinion of the investigator, potentially pose an increased risk to the subject.
- History of melanoma.
- Known history of illness or adverse reaction to cold insult (e.g., cryoglobulinemia, cold urticaria, paroxysmal cold hemoglobinuria, Reynaud's disease).
- History of abnormal wound healing or abnormal scarring
- Inability or unwillingness to comply with the study requirements.
- Subject is pregnant or planning to become pregnant while enrolled in the study.
- Subject is lactating.
- Current enrollment in a clinical study of any other unapproved investigational drug or device.
- Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect response or participation in this clinical study, or would pose an increased or unacceptable risk to the subject.
Sites / Locations
- Clear Dermatology & Aesthetics Center
- Zel Skin and Laser Specialists
- Dermatology, Laser and Vein Specialists of the Carolinas
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Treatment with cryotherapy
Arm Description
Dermal Cooling System
Outcomes
Primary Outcome Measures
Improvement in appearance in the treatment area
Improvement in appearance in the treated area at the 3-month follow-up visit, as determined by the Physician Global Assessment (PGA).
Secondary Outcome Measures
Incidence of procedure related adverse events
• Safety of the treatment as determined by the incidence of device- or procedure-related serious adverse events
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03282994
Brief Title
Dermal Cooling System for Cryotherapy of Common Skin Conditions
Official Title
Evaluation of the Dermal Cooling System for Cryotherapy of Common Skin Conditions
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
July 19, 2017 (Actual)
Primary Completion Date
November 17, 2018 (Actual)
Study Completion Date
November 17, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
R2 Dermatology
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
Prospective, non-randomized, open-label study to evaluate the dermal cooling system for cryotherapy of common skin conditions.
Detailed Description
The purpose of this study is to establish that controlled localized cooling with the Dermal Cooling System will elicit an improvement in the cosmetic appearance of benign superficial lesions associated with common skin conditions that are currently being treated with cryosurgical methods.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Skin Lesion
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
34 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Treatment with cryotherapy
Arm Type
Experimental
Arm Description
Dermal Cooling System
Intervention Type
Device
Intervention Name(s)
Dermal Cooling System
Intervention Description
Cryotherapy
Primary Outcome Measure Information:
Title
Improvement in appearance in the treatment area
Description
Improvement in appearance in the treated area at the 3-month follow-up visit, as determined by the Physician Global Assessment (PGA).
Time Frame
3-months
Secondary Outcome Measure Information:
Title
Incidence of procedure related adverse events
Description
• Safety of the treatment as determined by the incidence of device- or procedure-related serious adverse events
Time Frame
less than 12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Male or female subjects > 18 years of age.
Subject has benign superficial lesion(s) associated with common skin conditions amenable to cryosurgical treatment including, for example, psoriasis, acne, rosacea, and sebaceous hyperplasia.
Subject is willing to have up to 40 test sites treated.
Subject has read and signed a written informed consent form.
Exclusion Criteria:
Physician prescribed procedures in the area of intended treatment in the previous 6 months (e.g., photodynamic therapy, intense pulsed light therapy, laser surgery).
Dermatological conditions (e.g. vitiligo, open wounds, infection, pre-cancerous or malignant lesions) in the location of the treatment sites that would, in the professional opinion of the investigator, potentially pose an increased risk to the subject.
History of melanoma.
Known history of illness or adverse reaction to cold insult (e.g., cryoglobulinemia, cold urticaria, paroxysmal cold hemoglobinuria, Reynaud's disease).
History of abnormal wound healing or abnormal scarring
Inability or unwillingness to comply with the study requirements.
Subject is pregnant or planning to become pregnant while enrolled in the study.
Subject is lactating.
Current enrollment in a clinical study of any other unapproved investigational drug or device.
Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect response or participation in this clinical study, or would pose an increased or unacceptable risk to the subject.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kristine Tatsutani, PhD
Organizational Affiliation
R2 Dermatology
Official's Role
Study Director
Facility Information:
Facility Name
Clear Dermatology & Aesthetics Center
City
Scottsdale
State/Province
Arizona
ZIP/Postal Code
85255
Country
United States
Facility Name
Zel Skin and Laser Specialists
City
Edina
State/Province
Minnesota
ZIP/Postal Code
55424
Country
United States
Facility Name
Dermatology, Laser and Vein Specialists of the Carolinas
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28207
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Dermal Cooling System for Cryotherapy of Common Skin Conditions
We'll reach out to this number within 24 hrs